T he a 1 -adrenoceptors (a 1 -ARs) contribute to various physiological actions in and around the eye, and are, for example, involved in regulation of protein secretion in the lacrimal gland, 1 tone of ocular blood vessels, 2, 3 and pupil diameter. 4 The a 1 -AR family is composed of three subtypes, denoted a 1A , a 1B , and a 1D . 5 All three receptor subtypes are activated by catecholamines and can mediate constriction of smooth muscle cells. 6 Pharmacological studies in various species that used selective antagonists for individual a 1 -AR subtypes suggested that the a 1A -AR plays a major role in adrenergic pupil size regulation. [7] [8] [9] [10] [11] [12] Clinical support for these findings came in 2005 with the description of ''intraoperative floppy iris syndrome'' (IFIS), a triad of billowing iris, iris prolapse, and progressive pupil constriction during cataract surgery. 13 Intraoperative floppy iris syndrome has initially been observed in patients under medication with the a 1A -AR-selective antagonist tamsulosin for treating lower urinary tract symptoms suggestive of benign prostatic hyperplasia, 13 but meanwhile also has been demonstrated with many other drugs having affinity for a 1 -ARs. 14 Although the basis of IFIS is thought to be antagonism of the a 1A -AR subtype located in the iris dilator muscle, there are still some doubts regarding the pathophysiology. One observation that cannot be explained pharmacologically is that IFIS has been reported even years after discontinuation of the medication. 13, 15, 16 Thus, it has been proposed that IFIS may result from a combination of pharmacologic inhibition of iris smooth muscle contraction and long-term smooth muscle atrophy related to drug accumulation in adjacent iris pigment epithelial cells. 17 The goal of the present study was to examine the hypothesis that the a 1A -AR subtype mediates pupil dilation and trophic effects in the mouse iris. Moreover, the contribution of the other two a 1 -AR subtypes to these effects has been tested. Because of the lack of highly selective pharmacological blockers for some of the a 1 -ARs, gene-targeted mice lacking one of the three a 1 -AR subtypes (a 1A -AR À/À , a 1B -AR À/À , a 1D -AR À/À , respectively) were used in this study.
MATERIALS AND METHODS

Animals
All studies were performed in accordance with the ARVO statement for the Use of Animals in Ophthalmic and Vision , and a 1D -AR À/À mice has been described previously. [18] [19] [20] Each genotype has been backcrossed with C57BL/6Slc mice for nine generations and maintained on a C57BL/6Slc background. The genotype of each mouse was determined by PCR of DNA isolated from tail biopsies. Mice were housed under standardized conditions with a 12-hour light/dark cycle, temperature of 22 6 28C, humidity of 55% 6 10%, and with free access to food and tap water. For experiments, male mice at the age of 8 to 9 months were used.
Real-Time PCR Analysis
Expression of a 1 -AR mRNA was quantified in iris tissue from wild-type (C57BL/6Slc), a 1A -AR
, and a 1D -AR À/À mice using real-time PCR. After mice had been killed by CO 2 inhalation, the eyes were immediately removed and placed in ice-cold PBS (Invitrogen, Karlsruhe, Germany). Then, the iris was isolated by the use of fine-point tweezers under a dissecting microscope, transferred into a 1.5-mL tube, and immediately snap frozen.
Subsequently, the tissue was homogenized in lysis buffer using a homogenization device (Schwingmühle MM 300; Retsch GmbH, Haan, Germany; Lysing Matrix D MP; MP Biomedicals, Illkirch, France). After homogenization, total RNA was extracted with the RNeasy Kit (QIAGEN, Hilden, Germany) according to the manufacturer's protocol. After isolation, mRNA was reverse transcribed with Moloney Murine Leukemia Virus reverse transcriptase and random hexamers (Promega, Mannheim, Germany). Quantitative PCR analysis was performed with the ViiA 7 system (Applied Biosystems, Darmstadt, Germany). We used SYBR green for the fluorescent detection of DNA generated during PCR. The PCR was performed in a total volume of 10 lL and 23 SYBR Green master mix (QIAGEN); 2 lL cDNA corresponding to 13 ng RNA was used as template. Published sequences for mouse a 1A -AR (NM_013461), a 1B -AR (NM_007416), and a 1D -AR (NM_013460) were used to design primers for PCR amplification. Primer sequences were a 1A -AR sense 5 0 -GCG GTG GAC GTC TTA TGC T-3 0 and antisense 5 0 -TCA CAC CAA TGT ATC GGT CGA-3 0 ; a 1B -AR sense 5 0 -CCT GGT CAT GTA CTG CCG A-3 0 and antisense 5 0 -GAC TCC CGC CTC CAG ATT C-3 0 ; a 1D -AR sense 5 0 -AGT TGG TGA CCG TCT GCA AGT-3 0 and antisense 5 0 -CGC TGT GGT GGG AAC CGG CAG-3 0 ; b-actin sense 5 0 -CAC CCG CGA GCA CAG CTT CTT T-3 0 and antisense 5 0 -AAT ACA GCC CGG GGA GCA TC-3 0 . Standard negative controls were used for the PCR. A control lacking reverse transcriptase was used to check for DNA contamination of the isolated RNA. We also used a reverse transcription control without RNA to check for contamination of the chemicals used. In both controls, no PCR product was detected, indicating that genomic DNA was absent and the purity of the chemicals was high. For positive control, we used RNA isolated from mouse brain. The expression levels of individual a 1 -AR subtype mRNA were normalized to b-actin using the DCt method. Parallelism of standard curves was confirmed.
Measurement of Pupil Diameter
Pupil diameter was determined in conscious restrained mice under a stereomicroscope (SZ61; Olympus Deutschland GmbH, Hamburg, Germany). First, a photograph of the right eye was taken before the application of eyedrops. The diameter of the pupil in this photograph was considered as the baseline diameter. Then, 4 lL of 5% phenylephrine hydrochloride eyedrops (Neosynephrin-POS 5%; Ursapharm Arzneimittel GmbH, Saarbrücken, Germany) were applied into the right eye by using a micropipette. After 2, 4, 6, 8, 10, 12, 14, 16, 18, and 20 minutes, photographs of the right eye were taken. The illumination (»1000 lux) was standardized and measured before the start of each experiment using a luxmeter (LM37; Carl Roth GmbH, Karlsruhe, Germany). From each photograph, the vertical and horizontal pupil diameters were measured by a masked evaluator and the average calculated.
Measurement of Iris and Iris Muscle Thickness
For histological examinations, mice were killed and their eyes immediately enucleated. After enucleation, a high interindividual variability in pupil diameter was observed. Although some pupils remained stable for a few minutes, others markedly dilated directly after enucleation. To enable iris and iris muscle measurements under standardized conditions, each eye was placed for 5 minutes into PBS containing 0.03% of carbachol (Isopto-Carbachol 3%; Alcon Pharma GmbH, Freiburg, Germany) at room temperature to constrict the pupil. Next, each eye was embedded in Tissue-Tek O.C.T Compound (Sakura Finetek Germany GmbH, Staufen, Germany) and snap frozen in liquid nitrogen in a sagittal orientation. Frozen tissue samples were sectioned at 10-lm thickness and adhered onto chromium-gelatin-coated slides to prevent tissue detachment. To enable iris and iris muscle measurement at a standardized localization, only central sagittal sections of the eye containing the pupil and the optic nerve head were used for analysis (Fig.  1A) . Because the iris sphincter and dilator muscles were partially masked by melanin pigment granula, preventing exact measurement of their thickness, we bleached the tissue sections before examination (Figs. 1B, 1C ). For bleaching, we used a protocol that has recently been established by our laboratory to rapidly and effectively remove melanin pigment. 21 Briefly, cryosections were post-fixed in 4% paraformaldehyde for 20 minutes before depigmentation using 10% H 2 O 2 diluted in PBS at 658C for 120 minutes and routinely stained with hematoxylin and eosin. Iris thickness was not affected by bleaching (data not shown). The iris and sphincter thicknesses of the stained sections were measured at 3200 magnification, whereas the iris dilator thickness was measured at 3400 magnification under a bright-field microscope. For each eye, a total of 12 iris or iris muscle thickness measurements were obtained from standardized positions; 6 from the central and 6 from the peripheral iris region measured in the peripheral, middle, and proximal aspects, respectively.
Statistical Analysis
Data of mRNA expression are presented as box plots with the ends of the whiskers representing the minimum and maximum. For statistical analysis of a 1 -AR mRNA expression levels, the Kruskal-Wallis test, followed by the Dunn's multiple comparison test, was used. Pupil responses are presented as percentage of change in diameter from baseline diameter (mean 6 SE), and for comparisons of time-dependent pupil responses between individual mouse genotypes, repeatedmeasures ANOVA followed by the Tukey test were used. Iris and iris muscle thicknesses were expressed as mean 6 SE and compared by one-way ANOVA followed by the Tukey test. The level of significance a was set at 0.05. Multiple comparisons were tested at a Bonferroni-adjusted a level, and n represents the number of mice per group
RESULTS
Expression of a 1 -AR in the Iris
Using real-time PCR, we detected mRNA of all three a 1 -AR subtypes in iris tissue from wild-type mice (Fig. 2) . Remarkably,
a 1A -AR mRNA and a 1B -AR mRNA were more abundant than a 1D -AR mRNA. No significant difference was seen between a 1A -AR mRNA and a 1B -AR mRNA expression levels. In mice lacking a single a 1 -AR subtype, no compensatory changes in mRNA expression for the remaining two subtypes were observed (Fig.  3) .
Pupil Diameter Changes in Response to Phenylephrine
Baseline pupil diameter before application of phenylephrine was 566 6 25 lm, 587 6 19 lm, 564 6 21 lm, and 553 6 26 lm in wild-type, a 1A -AR
, and a 1D -AR À/À mice, respectively, and did not differ between individual mouse genotypes. In wild-type mice, phenylephrine evoked marked pupil dilation already 2 minutes after application (Fig. 4) . Change in pupil diameter from baseline reached its maximum of 49% 6 5% 4 minutes after phenylephrine application and remained constant for 20 minutes. In a 1D -AR À/À mice, similar to wild-type mice, a maximum of 51% 6 10% in pupil dilation from baseline was observed after 4 minutes, and the mydriasis also remained stable for 20 minutes. In a 1B -AR À/À mice, the maximum change in pupil diameter was 39% 6 8% and slightly smaller compared with wild-type and a 1D -AR À/À mice, and the diameter already started to decrease within the time frame of 20 minutes. The time course of pupil dilation differed significantly from that of wild-type and a 1D -AR À/À mice. In a 1A -AR À/À mice, the maximal change of pupil diameter in response to phenylephrine was weakest among FIGURE 2. Relative mRNA expression of individual a 1 -AR subtypes normalized to b-actin transcripts in iris tissue from wild-type mice. Data are presented as box plots with the ends of the whiskers representing the minimum and maximum (n ¼ 7; ***P < 0.001 a 1A versus a 1D ; *P < 0.05 a 1B versus a 1D ). 
Iris Morphology
Carbachol-preconstricted pupil diameter assessed in sagittal cryosections of the mouse eye globe was 354 6 23 lm, 327 6 24 lm, 348 6 27 lm, and 365 6 42 lm, and did not differ between individual mouse genotypes. Central iris thickness was 64 6 3 lm, 58 6 2 lm, 59 6 2 lm, and 66 6 2 lm in wild-type, a 1A -AR
, and a 1D -AR À/À mice, respectively, and did not differ among the four mouse genotypes (Fig. 5A ). Peripheral iris thickness was 29 6 1 lm, 28 6 1 lm, 28 6 1 lm, and 30 6 1 lm in wild-type,
, and a 1D -AR À/À mice, respectively, and was also similar among all genotypes (Fig. 5B) . The thickness of the iris sphincter muscle was 25 6 1 lm, 23 6 1 lm, 25 6 1 lm, and 27 6 1 lm in wild-type, a 1A -AR À/À , a 1B -AR À/À , and a 1D -AR À/À mice, respectively, and was also similar in the four mouse genotypes (Fig. 5C) . Also, the dilator muscle had a similar thickness in all genotypes: 9.1 6 0.2 lm, 8.7 6 0.2 lm, 9.0 6 0.3 lm, and 9.3 6 0.3 lm in wild-type, a 1A -AR
, and a 1D -AR À/À mice, respectively (Fig. 5D) .
DISCUSSION
There are several major new findings in the present study. First, pupil responsiveness to adrenergic stimuli in mice was mediated predominantly by the a 1A -AR subtype with a minor contribution of the a 1B -AR subtype. Second, mRNA expression levels of individual a 1 -AR subtypes were in good agreement with the contribution of the respective subtypes to pupil dilation, and disruption of a single a 1 -AR subtype gene did not have significant effects on the mRNA expression levels of the remaining two receptor subtypes, which is in line with previous studies in other tissues. 20, 22 Because the specificity of commercially available antibodies directed against individual a 1 -AR subtypes appears to be limited in mice, 23, 24 we chose not to quantify receptor proteins. Third, the lack of a single a 1 -AR subtype did not affect iris and iris muscle thickness. This is the first study in mice that has investigated the expression of individual a 1 -AR subtypes in the iris and their involvement in adrenergic pupil diameter regulation. Previous studies in rats 25 and rabbits 9, 12, 26 have demonstrated that in iris tissue the a 1A -AR subtype is either expressed most abundantly or equally as high as the a 1B -AR, whereas the a 1D -AR subtype is least abundantly expressed both at the mRNA and protein levels. Our study extends these findings to the mouse iris, indicating that this is well conserved in mammals.
The functional role of a 1 -ARs has been examined in various animal species. For example, in cats, the receptor mediating iris dilation has been described as an atypical receptor, unclassifiable as either a 1 -AR or a 2 -AR. 27 Studies in rats suggested that sympathetic mydriasis is mediated by the a 1A -AR subtype. 7, 8 However, it has been suggested that the a 1B -AR may be involved in mediating contraction of rat irideal blood vessels. 28 An attempt to assess the functional relevant a 1 -AR subtype in pigs has been hampered, because binding of the a 1 -AR antagonist prazosin to melanin was too high to detect any of the a 1 -AR subtypes. 12 Many functional studies have been performed in rabbits. Most of them indicated that a 1A -AR is the main mediator of adrenergic pupil dilation, but differences in affinity to prazosin have been observed dependent on the state of iris pigmentation. 4, 9, 11, 29 Another study suggested that the low-affinity phenotype of the a 1A -AR mediates adrenergic pupil dilation in humans. 4 The present study in mice is in agreement with most of the previous studies conducted in other species, demonstrating that the a 1A -AR subtype plays a predominant role in adrenergic pupil dilation.
Another intriguing question addressed in the present study was whether the lack of individual a 1 -AR subtypes resulted in iris dilator thinning. Because IFIS has been observed in patients who had been off tamsulosin for more than 1 year, Chang and Campbell 13 hypothesized that a ''disuse atrophy'' of the iris dilator muscle caused by chronic pharmacological blockade of a 1 -ARs may contribute to the syndrome. Studies in humans who had been on medication with a 1 -AR antagonists, primarily tamsulosin, supported this hypothesis by demonstrating peripheral iris or iris dilator muscle thinning. 30, 31 Moreover, a case series in humans on topical medication with the a 1 -AR antagonist, bunazosin, reported signs of iris dilator muscle atrophy together with changes of pigment granules in melanocytes and clump cells, and thus suggested that IFIS should not only be attributed to binding of a specific drug to a 1 -ARs, but also to a drug-melanin interaction causing dilator muscle atrophy. 32 In support of this concept, a recent study in rabbits suggested that chronic exposure to the a 1 -AR antagonists tamsulosin and silodosin causes atrophy of the iris dilator muscle due to a drug-melanin interaction in adjacent pigment epithelial cells. 17 In the present study, we found no differences in iris dilator muscle thickness between wild-type mice and any of the mouse genotypes lacking a single a 1 -AR subtype. There are several possible explanations for the differences between our observations in mice and the previous in humans and rabbits.
First, species differences are a possible factor that needs to be considered. Although in humans and rabbits, like in mice, adrenergic pupil dilation appears to be mediated predominantly by the a 1A -AR subtype, we cannot rule out the possibility of species differences in the coupling of a 1 -ARs to growth responses. For example, a study in cultured rat cardiomyocytes that used different a 1 -AR antagonists suggested that the a 1A -AR subtype mediates trophic effects in these cells. 33 In contrast, studies in a 1 -AR knockout mice demonstrated that the a 1B -AR subtype exerted trophic effects in response to a 1 -AR agonists in the heart and in blood vessels. 34, 35 Although the lack of the a 1B -AR subtype could not be compensated in the cardiovascular system by the remaining two subtypes in this knockout mouse model, we cannot completely exclude the possibility that in the iris of knockout mice a functional compensation by the remaining two a 1 -AR subtypes or other receptors may have occurred so that potential a 1 -AR-mediated trophic effects were eventually masked. Second, a thinning of the dilator muscle or the peripheral iris in a 1 -AR antagonist-treated subjects found in previous studies may have been secondary to reduced pupil diameter and thus increased stretch and thinning of the peripheral iris. In contrast to the present study, in which iris and iris muscle thickness were measured in histological sections with a standardized pupil diameter, the pupil diameter was either not reported or smaller in a 1 -AR antagonist-treated subjects in the previous studies. 17, 30, 31 Third, all previous studies measured iris and iris muscle thickness in subjects treated with a 1 -AR antagonists, whereas in the present study, the measurements were performed in mice lacking single a 1 -AR subtypes. Hence, it is also possible that in the previous studies another factor, not necessarily related to an a 1 -AR signaling pathway, caused iris dilator atrophy due to chronic exposure to the respective antagonists. A drug-melanin interaction, as suggested by Goseki et al., 17, 32 may be one possible explanation. Because the interaction between all a 1 -AR antagonists and the receptors is reversible and because there are no data from other tissues indicating that blockade of a 1 -ARs causes irreversible atrophy, there remains the unresolved question as to why IFIS can occur even years after drug discontinuation.
In conclusion, this is the first study to provide evidence that a 1A -AR and a 1B -AR subtypes are most abundantly expressed and functionally active in the mouse iris. The mRNA expression data and the pharmacological findings are in line with previous studies in other species, including humans. However, we found no evidence that the lack of a single a 1 -AR subtype causes atrophy in the mouse iris. The a 1 -FIGURE 4. Representative pictures of eyes from a wild-type mouse made during pupil diameter measurements before (A) and 4 minutes after application of phenylephrine (B) to demonstrate changes in pupil diameter. (C) Graph showing relative changes in pupil diameter from wild-type, a 1A -AR À/À , a 1B -AR À/À , and a 1D -AR À/À mice to the a 1 -AR agonist phenylephrine. Values are expressed as mean 6 SE (n ¼ 12 per genotype; ***P < 0.001 a 1A versus all other groups; **P < 0.01 a 1B versus wild-type and a 1D ).
